Entrepreneur in biotechnology. Licensing-in & -out. Marketing and Business Development of innovative technologies in Life-Sciences. Project & Team Management, Antoine Prestat if the CEO of PEP THERAPY. PEP-Therapy is a medical biotechnology company, which develops first-in-class peptides as targeted therapies in oncology. PEP-Therapy has developed a proprietary Cell Penetrating and Interfering Peptides (CP&IP) technology for the development of its therapeutic products. These innovative peptides penetrate cells and then block relevant intracellular protein-protein interactions, thus inhibiting specifically key pathological mechanisms. Antoine was senior project manager with Genopole and Director of Business Development with Ifremer.